• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Heather Danks Named Chief Technology Officer at LEX Diagnostics

    Vitalchat Awarded Patent for Patient Monitoring, Bandwidth Conservation Tech

    South Korean Regulators Authorize Expanded NeuroStar TMS Indications

    Ian T. Meredith Joins Avertix Medical’s Board

    Hologic, Bayer Team Up for Contrast-Enhanced Mammography
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Medtech’s Most Powerful M&A Drivers

    The Link Between Medtech and Connected Medical Devices

    Is the FTC Partly Responsible for Muted M&A Activity?

    Holistic Risk Management: Navigating the Future’s Uncertainties

    Defining End of Life for Medical Devices
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    NDH Medical Inc.

    JBC Technologies

    Halkey-Roberts Corporation

    Providence Enterprise USA Inc.

    Cirtec Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing

    How In Silico Simulations Can Slash Medical Device Development Risk

    The Top 7 AI Applications Transforming Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    NDH Medical Inc.

    JBC Technologies

    Halkey-Roberts Corporation

    Providence Enterprise USA Inc.

    Cirtec Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA Grants Breakthrough Device Designation to Woebot Health’s WB001

    A digital therapeutic for the treatment of postpartum depression.

    FDA Grants Breakthrough Device Designation to Woebot Health’s WB001
    WB001 is an 8-week treatment delivered via a patient’s smartphone that combines cognitive behavioral therapy and elements of interpersonal psychotherapy with an understanding of the lived experience of PPD to reduce symptoms of depression.
    Charles Sternberg, Assistant Editor06.03.21
    The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Woebot Heath’s digital therapeutic for the treatment of postpartum depression (PPD).
     
    WB001 is an investigational digital therapeutic, delivered over eight weeks via a patient’s smartphone, that combines cognitive behavioral therapy (CBT) and elements of interpersonal psychotherapy (IPT) with a deep understanding of the lived experience of PPD to reduce symptoms of depression. Intended as a prescription-only treatment to be used under the supervision of a clinician, WB001 also features the company’s proprietary relational agent Woebot, which was shown in a recent study to be capable of forming a bond with patients to support meaningful engagement and, potentially, better outcomes.
     
    The FDA’s grant of breakthrough designation will allow Woebot Health to interact with the FDA through several different program options to efficiently address topics as they arise during the premarket review phase, receive feedback from the FDA, identify areas of agreement in a timely way and receive priority review of its marketing submission.
     
    About Postpartum Depression (PPD)
    PPD, according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM 5), is a major depressive episode with symptom onset during pregnancy or within four weeks of delivery. As many as 20 percent of women who have given birth experience PPD which, when left untreated, can present immediate and long-term risk to the mother and infant. Despite the prevalence and risks of PPD, almost 60 percent of women who experience PPD symptoms do not receive a clinical diagnosis. Among those who do screen positive for the condition, less than 25 percent receive follow-up care. Treatment options are few and include an expensive intravenous therapeutic, antidepressant drugs and a referral to a psychiatrist or therapist, a solution hampered by long wait times for appointments and the associated stigma of asking for help.
     
    “The odds are truly stacked against women who are hit with barriers to treatment right after childbirth, especially those of lower socioeconomic status and/or minority populations who are at a higher risk for PPD but face ongoing and concerning care disparities that pervade the mental healthcare system,” said Woebot Health’s chief clinical officer Athena Robinson, Ph.D. “WB001 is designed to significantly reduce barriers to PPD care that often thwart help-seeking and treatment engagement behaviors—including lack of time, childcare issues, stigma and fear of loss of parental rights. We’re proud to be offering a scalable, clinically-validated digital treatment for such a pervasive, serious and heartbreaking condition.”
     
    Treating PPD in a Noninvasive Way
    Proprietary research conducted with postpartum adults and clinicians at the onset of WB001’s development informed the treatment’s engagement and relational characteristics, which include targeted topic areas, empathy, normalization, and clinical memory. Designed with the nuance of the PPD experience in mind and combining the active elements of proven therapeutic approaches delivered by a relational agent, WB001 is designed to increase patient motivation and treatment efficacy in a noninvasive way.
     
    Decades of published research support CBT and IPT in the treatment of depression including PPD specifically; CBT and IPT are recommended by the American Psychiatric Association (APA), American College of Obstetricians and Gynecologists (ACOG), United States Preventive Services Task Force (USPSTF) and the National Institute for Health and Care Excellence (NICE) for the treatment of PPD.
     
    WB001’s content includes psychoeducational lessons and CBT- or IPT-specific tools. The lessons teach PPD-specific information to normalize and contextualize postpartum experiences, as well as provide mood management and mental health promotion. The CBT-based tools guide patients through behavioral practices such as thought challenging, behavioral activation, mindfulness and self-care, while the IPT-based tools address relationship transitions, communication analysis and skill building, as well as role/identity changes.
    Related Searches
    • Digital Health
    Related Knowledge Center
    • Digital Health
    Suggested For You
    Breakthrough Device Designation Granted for New Neuromodulation Platform Breakthrough Device Designation Granted for New Neuromodulation Platform
    First CellFX Procedure Performed in Canada First CellFX Procedure Performed in Canada
    RedDress’ ActiGraft System Receives New FDA Clearance RedDress’ ActiGraft System Receives New FDA Clearance
    Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    Precision Coating Merges with N2 Biomedical Precision Coating Merges with N2 Biomedical
    FDA Approves Abbott FDA Approves Abbott's Portico with FlexNav TAVR System
    Medical Devices Market to Top $671.49 Billion by 2027 Medical Devices Market to Top $671.49 Billion by 2027
    Improved Outcomes Proven With Insulet’s Omnipod 5 System Improved Outcomes Proven With Insulet’s Omnipod 5 System
    Molli Surgical Molli Surgical's Breast Tumor Marker
    The Benefits of Computer Vision Technology for Healthcare Applications The Benefits of Computer Vision Technology for Healthcare Applications
    Masimo Launches Single-Patient-Use rainbow SuperSensor in Europe Masimo Launches Single-Patient-Use rainbow SuperSensor in Europe
    Vertigo Treatment Receives FDA Breakthrough Device Designation Vertigo Treatment Receives FDA Breakthrough Device Designation
    Quanta Raises $245 Million in Series D Funding Round Quanta Raises $245 Million in Series D Funding Round
    Glytec Appoints Nausheen Moulana as Chief Technology Officer Glytec Appoints Nausheen Moulana as Chief Technology Officer
    Stryker Buys Gauss Surgical Stryker Buys Gauss Surgical

    Related Breaking News

    • Breakthrough Device Designation Granted for New Neuromodulation Platform

      Breakthrough Device Designation Granted for New Neuromodulation Platform

      In a pilot study treating refractory epilepsy with Neuroelectrics’ Starstim platform, patients experienced a 44 percent median reduction in seizure frequency.
      Business Wire 09.22.21

    • First CellFX Procedure Performed in Canada

      First CellFX Procedure Performed in Canada

      Pulse Biosciences expands its controlled launch of the CellFX System into the country.
      Business Wire 09.22.21

    • RedDress’ ActiGraft System Receives New FDA Clearance

      RedDress’ ActiGraft System Receives New FDA Clearance

      ActiGraft Ver.02 System is intended for the safe and rapid POC preparation of an in-vitro blood clot.
      Globe Newswire 09.22.21


    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      The two deals will strengthen Heraeus' healthcare and medtech portfolio.
      Heraeus 09.22.21

    • Surgical
      Precision Coating Merges with N2 Biomedical

      Precision Coating Merges with N2 Biomedical

      Expands its medical coatings platform.
      Ampersand Capital Partners 09.20.21

    Loading, Please Wait..

    Trending
    • RJG Names Winners Of 2023 RJG Mold Smart Award
    • Diabetes Innovation: MIT Engineers Unveil Implantable Device With Oxygen Factory
    • A New Approach To Post-Market Surveillance
    • Danaher Names New Environmental And Applied Solutions Company Veralto
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    Breaking News
    • Heather Danks Named Chief Technology Officer at LEX Diagnostics
    • Vitalchat Awarded Patent for Patient Monitoring, Bandwidth Conservation Tech
    • South Korean Regulators Authorize Expanded NeuroStar TMS Indications
    • Ian T. Meredith Joins Avertix Medical’s Board
    • Hologic, Bayer Team Up for Contrast-Enhanced Mammography
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Superior Subtractive Solutions for Machining Medtech
    • Medical Device Industry Experts' Thought on Assembly & Automation
    • Power Trip: A Discussion of Custom Medical Electronics
    • The MDR Transition: An Opportunity for Design Change?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Curcumin May Be As Effective as PPI for Indigestion
    Adding Human Milk Component to Formula Linked to Long-term Cognitive Benefits for Babies
    Women in Nutraceuticals Launches Pilot Mentorship Program
    Coatings World

    Latest Breaking News From Coatings World

    WEG Among the Best Companies in Brazil in 2023
    EMPA Develops Flame Resistant Epoxy Resin
    Becker’s Global Mental Health Program Shows Positive Impact
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Heather Danks Named Chief Technology Officer at LEX Diagnostics
    Vitalchat Awarded Patent for Patient Monitoring, Bandwidth Conservation Tech
    South Korean Regulators Authorize Expanded NeuroStar TMS Indications
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Nexcella Completes 2nd NXC-201 Engineering Batch
    Almirall Upgrades Werum PAS-X MES
    Rentschler Names Industry Veterans to Leadership Posts
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    GK Hair Expands Color Range to 125 Hues
    WPO and AIPIA Sign MoU to Collaborate on Smart Packaging
    SuperstarBots & Skin Match Redefine Personalized Beauty Recommendations with Social Media Chatbot
    Happi

    Latest Breaking News From Happi

    Daniel C. Liebler Wins 2023 RIFM Board of Directors Excellence in Science Award
    NAD Refers SBLA Beauty To Federal Trade Commission
    Altuzza Fashion Show Features Hairstyles by Jawara Using Fekkai Haircare Products
    Ink World

    Latest Breaking News From Ink World

    HYBRID Software’s PrintFusion for Koenig & Bauer
    Fujifilm Announced European Release of the Acuity Prime Hybrid
    Pacific Coatings Show Invites Industry to Top-Class Programs
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Vibrant Labelexpo Europe 2023 concludes in Brussels
    Kenco Label & Tag adds sheeting system from Daco Solutions
    Bastille Parfums strengthens traceability with Avery Dennison RFID technology
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Lenzing Earns EU Ecolabel at Indonesian Plant
    Albis Starts Up Extra Wide Carding, Blending Line
    Ahlstrom Launches Nonwoven Laundry Care Product
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    AOFAS, Arthritis Foundation Award Grants to Fuel Ankle Arthritis Research
    Lincotek Marks its 50th Anniversary
    FDA OKs Standalone Indication for ChoiceSpine's Blackhawk Ti Cervical Spacer
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Le Biscuit Boosts Omnichannel Operations with Zebra Technologies
    German Government, Bavaria Commit Support to ams OSRAM
    ASSA ABLOY Acquires Evolis

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login